References:

£Û1£ÝLeasher JL,Bourne RRA,Flaxman SR,et al.Global estimates on the number of people blind or visually impaired by diabetic retinopathy:a meta-analysis from 1990 to 2010£ÛJ£Ý.Diabetes Care,2016,39(9):1643-1649.
£Û2£ÝBarmas-Alamdari D,D¬ðSouza HS,Kapoor KG,et al.Intravitreal ziv-aflibercept:a comprehensive review£ÛJ£Ý.Seminars in Ophthalmology,2019,34(6):420-435.
£Û3£ÝGiuliari GP,Guel DA,Gonzalez VH.Pegaptanib sodium for the treatment of proliferative diabetic retinopathy and diabetic macular edema£ÛJ£Ý.Current Diabetes Reviews,2009,5(1):33-38.
£Û4£ÝStahl A,Lepore D,Fielder A,et al.Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW):an open-label randomised controlled trial£ÛJ£Ý.Lancet,2019,394(10208):1551-1559.
£Û5£ÝNetwork DRCR,Elman MJ,Aiello LP,et al.Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema£ÛJ£Ý.Ophthalmology,2010,117(6):1064-1077.e35.
£Û6£ÝArvindekar A,More T,Payghan PV,et al.Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi£ÛJ£Ý.Food & Function,2015,6(8):2693-2700.
£Û7£ÝJung HA,Ali MY,Choi JS.Promising inhibitory effects of anthraquinones,naphthopyrone,and naphthalene glycosides,from Cassia obtusifolia on ¦Á-glucosidase and human protein tyrosine phosphatases 1B£ÛJ£Ý.Molecules,2016,22(1):28.
£Û8£ÝLee W,Yoon G,Hwang YR,et al.Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition£ÛJ£Ý.BMB Reports,2012,45(3):141-146.
£Û9£ÝAyoub AM,Gutberlet B,Preis E,et al.Parietin cyclodextrin-inclusion complex as an effective formulation for bacterial photoinactivation£ÛJ£Ý.Pharmaceutics,2022,14(2):357.
£Û10£ÝMugas ML,Calvo G,Marioni J,et al.Photosensitization of a subcutaneous tumour by the natural anthraquinone parietin and blue light£ÛJ£Ý.Scientific Reports,2021,11(1):23820.
£Û11£ÝLiu YJ,Chu SF,Yang SW,et al.Physcion and physcion 8-O-¦Â-glucopyranoside:a review of their pharmacology,toxicities and pharmacokinetics£ÛJ£Ý.Chemico-Biological Interactions,2019,310:108722.
£Û12£ÝShen MY,Liu YJ,Don MJ,et al.Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica£ÛJ£Ý.PLoS One,2011,6(11):e27480.
£Û13£ÝInalegwu AE,Aimola IA,Mohammed A.Physcion ameliorates pancreatic ¦Â-cell dysfunction and diabetes-related oxidative stress markers in type 2 diabetes rat model£ÛJ£Ý.Phytomedicine Plus,2021,1(4):100114.
£Û14£Ý¶Î»Ý»Ý,»Æ½¨Ã·,ÓÚËØÔÆ,µÈ.STZÌÇÄò²¡´óÊóÊÓÍøĤ²¡±äÄ£Ð͵ÄÔÙÆÀ¼Û£ÛJ£Ý.Öйú±È½ÏҽѧÔÓÖ¾,2013,23(5):12-18,79.
£Û15£ÝChan LY,Takahashi M,Lim PJ,et al.Eurotium cristatum fermented okara as a potential food ingredient to combat diabetes£ÛJ£Ý.Scientific Reports,2019,9:17536.
£Û16£ÝBoss JD,Singh PK,Pandya HK,et al.Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy£ÛJ£Ý.Investigative Ophthalmology & Visual Science,2017,58(12):5594-5603.
£Û17£ÝAbcouwer SF.M¨¹ller cell-microglia cross talk drives neuroinflammation in diabetic retinopathy£ÛJ£Ý.Diabetes,2017,66(2):261-263.
£Û18£ÝCao Y,Li X,Shi P,et al.Effects of L-carnitine on high glucose-induced oxidative stress in retinal ganglion cells£ÛJ£Ý.Pharmacology,2014,94(3/4):123-130.
£Û19£ÝVakifahmetoglu-Norberg H,Ouchida AT,Norberg E.The role of mitochondria in metabolism and cell death£ÛJ£Ý.Biochemical and Biophysical Research Communications,2017,482(3):426-431.
£Û20£ÝDong XB,Wang L,Song GR,et al.Physcion protects rats against cerebral ischemia-reperfusion injury via inhibition of TLR4/NF-kB signaling pathway£ÛJ£Ý.Drug Design,Development and Therapy,2021,15:277-287.
£Û21£ÝLupo G,Motta C,Giurdanella G,et al.Role of phospholipases A2 in diabetic retinopathy:in vitro and in vivo studies£ÛJ£Ý.Biochemical Pharmacology,2013,86(11):1603-1613.
£Û22£ÝLi JM,Wang JJ,Yu Q,et al.Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice:role of NADPH oxidase 4£ÛJ£Ý.Diabetes,2010,59(6):1528-1538.
£Û23£ÝMarco E,Jha J,Sharma A,et al.Are reactive oxygen species still the basis for diabetic complications?£ÛJ£Ý.Clinical Science,2015,129(2):199-216.
£Û24£ÝHui QY,Karlstetter M,Xu ZH,et al.Inhibition of the Keap1-Nrf2 protein-protein interaction protects retinal cells and ameliorates retinal ischemia-reperfusion injury£ÛJ£Ý.Free Radical Biology & Medicine,2020,146:181-188.
£Û25£ÝSharma A,Rizky L,Stefanovic N,et al.The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction£ÛJ£Ý.Cardiovascular Diabetology,2017,16(1):33.
£Û26£ÝTan SM,Sharma A,Stefanovic N,et al.Derivative of bardoxolone methyl,dh404,in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney disease£ÛJ£Ý.Diabetes,2014,63(9):3091-3103.
£Û27£ÝWang YH,Liu YP,Zhu JQ,et al.Physcion prevents high-fat diet-induced endothelial dysfunction by inhibiting oxidative stress and endoplasmic reticulum stress pathways£ÛJ£Ý.European Journal of Pharmacology,2023,943:175554.
£Û28£ÝMoon PD,Han NR,Lee JS,et al.Use of physcion to improve atopic dermatitis-like skin lesions through blocking of thymic stromal lymphopoietin£ÛJ£Ý.Molecules,2019,24(8):1484.